Physician profile
Basit Achakzai
NPI 1780903278
$1,887.35
in general payments reported to CMS, 2019-2025
12 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.71 · 2020: $148 · 2021: $29.08 · 2022: $430 · 2023: $470 · 2024: $408 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $849.69 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Trisalus Life Sciences, INC. | $426.37 | 2023-2025 | Trinav Infusion System |
| Boston Scientific Corporation | $217.03 | 2019-2025 | Embold Fibered, Spyglass Discover |
| Sirtex Medical INC | $174.75 | 2023-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Philips North America LLC | $66.13 | 2020 | |
| Varian Medical Systems, INC. | $39.17 | 2020 | |
| Medtronic, INC. | $33.13 | 2024-2025 | Osteocool Rf Ablation System |
| Stryker Corporation | $24.75 | 2020 | |
| Ethicon US, LLC | $15.73 | 2021 | |
| Bard Peripheral Vascular, INC. | $15.37 | 2025 | Powerport M.R.I. Implantable Port |
| Cook Medical LLC | $13.59 | 2023 | Rosch-Uchida |
| Siemens Medical Solutions USA, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basit Achakzai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.